---
document_datetime: 2023-09-21 20:32:22
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/ravicti-epar-all-authorised-presentations_en.pdf
document_name: ravicti-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.678129
conversion_datetime: 2025-12-19 03:08:52.956242
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| EU (MA) Number   | (Invented) name   | Strength   | Pharmaceuti cal Form   | Route of Administration   | Immediate Packaging   | Content (concentration)   | Pack size   |
|------------------|-------------------|------------|------------------------|---------------------------|-----------------------|---------------------------|-------------|
| EU/1/15/1062/001 | RAVICTI           | 1.1 g/ml   | Oral liquid            | Oral or gastroenteral use | bottle (glass)        | 25 ml                     | 1 bottle    |